Stock JAN JANONE INC.
Add to a list
To use this feature you must be a member
Log inSign up

News JanOne Inc.

Equities

JAN

US47089W1045

Market Closed - Nasdaq
Other stock markets
 21:30:01 06/05/2024 BST 		5-day change 1st Jan Change
4.13 USD +5.90% Intraday chart for JanOne Inc. +10.72% +644.14%
04-18 JanOne Files Prospectus for $100 Million Mixed Shelf Offering MT
04-15 North American Morning Briefing : Stock Futures -2- DJ

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
JanOne Files Prospectus for $100 Million Mixed Shelf Offering
MT
North American Morning Briefing : Stock Futures -2-
DJ
JanOne Inc. Reports Earnings Results for the Full Year Ended December 30, 2023
CI
JanOne Regains Compliance with Nasdaq's Listing Requirements
PR
JanOne Inc. announced that it expects to receive $0.6 million in funding
CI
JanOne Inc. announced that it expects to receive $0.3 million in funding from Live Ventures Incorporated
CI
JanOne Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Wall Street Set to Open Higher Thursday as Jobless Claims Fall, Ahead of Powell Speech
MT
Investors Await Jobless Claims Report, Powell Speech as US Futures Remain Flat in Thursday Trading
MT
Top Premarket Gainers
MT
JanOne to Present at the Dawson James 8th Annual Investment Conference
PR
JanOne to Present In Person and by Video at H.C. Wainwright's 25th Annual Global Investment Conference
PR
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain
PR
JanOne Wins 'Best Abstract' Award at the Ohio Society of Interventional Pain Physicians Annual Meeting
AQ
JanOne Wins "Best Abstract" Award at the Ohio Society of Interventional Pain Physicians Annual Meeting
PR
JanOne Raises $790,000 in Registered Direct Offering of Shares, Private Placement of Warrants
MT
JanOne Technologies Announces Closing of Registered Direct Offering Priced At-The-Market under Nasdaq Rules
PR
JanOne to Present Prior Phase II Data on Diabetic Neuropathy at the Ohio Society of Interventional Pain Physicians Annual Meeting
AQ
JanOne Technologies Announces Registered Direct Offering Priced At-The-Market under Nasdaq Rules
AQ
JanOne Prices Registered Direct Offering, Announces Concurrent Private Placement
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. JAN Stock
  4. News JanOne Inc.